Please login to the form below

Catalent Pharma Solutions

From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.

This is a FREE listing




Below are full profiles from other companies in this area

Company Details

Catalent Pharma Solutions

Telephone:+1 866 720 3148

Contact

Address:
14 Schoolhouse Road
Somerset
NJ
08873
United States

Latest content from PMHub

Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient Innovative Trials
Medscape presents Digital Health in Practice: Impact & Insights at Reuters #Pharma2020
Medscape Education Global
Modern Medical Affairs: How to Leverage Tech and Data as an MSL
Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with different healthcare stakeholders, plus much more. Impetus Digital
The Creative Engagement Group appoints Tom Griffiths from Saatchi & Saatchi Wellness as Strategy and Planning Director
The Creative Engagement Group has appointed experienced healthcare and digital strategist Tom Griffiths. The Creative Engagement Group